71 results
Page 2 of 4
6-K/A
EX-99.2
h3i06 w6kel8
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K
EX-99.2
xou15
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.2
o6nj740bf8ev28 xw9ld
5 Aug 21
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
EX-99.2
y0l2grk9u
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
EX-1.1
znzby
5 Mar 21
Current report (foreign)
8:15am
424B5
uu1eo3ml6xabb
5 Mar 21
Prospectus supplement for primary offering
7:55am
6-K
EX-5.2
42dy16zre
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
6-K
EX-1.1
j2es6n7g eyh
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
424B5
xsou8o9pu0n
8 Sep 20
Prospectus supplement for primary offering
7:31am
6-K
EX-99.2
du5sonyt3swpczu
6 Aug 20
Index to Unaudited Condensed Consolidated Financial Statements
6:53am
6-K
EX-99.2
v7xiha
5 May 20
Index to Unaudited Condensed Consolidated Financial Statements
6:01am
6-K
EX-99.1
zefl70
6 Apr 20
ObsEva SA Announces New Interim Chief Financial Officer
4:00pm
6-K
EX-99.2
g6jm5ki549l 45kc10o
13 Nov 19
Index to Unaudited Condensed Consolidated Financial Statements
4:00pm
F-3
n30mq17h9
7 Aug 19
Shelf registration (foreign)
8:24am
F-3
EX-5.2
p3n4 9e3trznjfje2
7 Aug 19
Shelf registration (foreign)
8:24am
F-3
EX-4.1
pow3txutx
7 Aug 19
Shelf registration (foreign)
8:24am